BioSpace News Archive

Singapore clinicians and scientists have discovered an unprecedented use of an FDA-approved drug to kill p53-defective cancer cells

MDxHealth SA announced that positive data and observations from multiple studies and patient registries demonstrating the value of SelectMDx and ConfirmMDx for Prostate Cancer diagnosis, will be presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), taking place in San Francisco, California, February 14-16, 2019.

Lascar Data Loggers Monitor Storage of Vaccines in Refrigerator

Immunicum announced a collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to evaluate ilixadencel in combination with Avelumab in multi-indication phase Ib/II study ILIAD.

Chipscreen Biosciences announce the signing of a collaboration agreement with Innovent Biologics, Inc. to evaluate the safety and tolerability of Chipscreen’s Chidamide and Innovent’s Sintilimab in combination with an anti-VEGF monoclonal antibody IBI305 in patients with advanced colorectal carcinoma.

Innovent Biologics, Inc. announced the signing of a collaboration agreement with Shenzhen Chipscreen Biosciences Co., Ltd.

AKL Research and Development announces its investigational medicine for osteoarthritis (OA) has been awarded a prestigious grant from Innovate UK, the leading government innovation agency.

A NEW breast cancer drug shown to significantly reduce the risk of cancer recurrence is being made available to women in Singapore via a Special Access Program.

Fifth Episode of New Switch4Good Podcast Series Now Available